Multimodal analysis of renal stones to explore new biomarkers of urolithiasis
https://doi.org/10.21886/2308-6424-2024-12-4-121-134
Abstract
Despite advances in minimally invasive surgery, urolithiasis still recurs within the first five years after the first episode in more than 50% of patients. Researchers continue to search for new crystallisation inhibitors, metaphylaxis strategies and laser sources for stone destruction. Therefore, to achieve these goals, it is necessary to study kidney stones not only as the result of an isolated process of pathological biomineralisation in the human body, but also as a biogenic mineral or rock that obeys universal patterns and has certain properties. Consequently, kidney stones need to be studied using methods that are widely used in the geological sciences for the study of minerals, such as computed microtomography and petrological analysis. In this review, the properties of kidney stones studied using various research methods used in geosciences are discussed. These properties are also considered as new biomarkers of urolithiasis. This review discusses how new data from multimodal stone analysis can be used to develop personalised metaphylaxis and treatment strategies for all types of urolithiasis, including the most common idiopathic calcium-oxalate urolithiasis.
Keywords
About the Authors
E. O. PopovaRussian Federation
Elena O. Popova
Moscow
Competing Interests:
None
S. Y. Tkachev
Russian Federation
Sergey Y. Tkachev.
Moscow
Competing Interests:
None
A. K. Karpenko
Russian Federation
Anastasia K. Karpenko.
Moscow
Competing Interests:
None
Yu. A. Lee
Russian Federation
Yuliya A. Lee.
Moscow
Competing Interests:
None
P. A. Chislov
Russian Federation
Pavel A. Chislov.
Moscow
Competing Interests:
None
S. H. Ali
Russian Federation
Stanislav H. Ali — Cand.Sc.(Med).
Moscow
Competing Interests:
None
A. M. Dymov
Russian Federation
Alim M. Dymov — Cand.Sc.(Med).
Moscow
Competing Interests:
None
A. Z. Vinarov
Russian Federation
Andrey Z. Vinarov — Dr.Sc.(Med.), Full Prof.
Moscow
Competing Interests:
None
A. A. Akovantseva
Russian Federation
Anastasiya A. Akovantseva.
Moscow
Competing Interests:
None
B. P. Ershov
Russian Federation
Boris P. Ershov.
Moscow
Competing Interests:
None
D. A. Golub
Russian Federation
Danila A. Golub.
Moscow
Competing Interests:
None
M. D. Shchekleina
Russian Federation
Maria D. Shchekleina.
Moscow
Competing Interests:
None
G. Y. Galechyan
Russian Federation
Gevorg Y. Galechyan.
Moscow
Competing Interests:
None
D. A. Bogoedov
Russian Federation
Daniil A. Bogoedov.
Moscow
Competing Interests:
None
E. R. Gafarova
Russian Federation
Elvira R. Gafarova.
Moscow
Competing Interests:
None
R. E. Musaelyan
Russian Federation
Roman E. Musaelyan.
Moscow
Competing Interests:
None
P. S. Timashev
Russian Federation
Peter S. Timashev — Dr.Sc. (Chem.), Full Prof.
Moscow
Competing Interests:
None
References
1. Khan SR, Pearle MS, Robertson WG, Gambaro G, Canales BK, Doizi S, Traxer O, Tiselius HG. Kidney stones. Nat Rev Dis Primers. 2016;2:16008. DOI: 10.1038/nrdp.2016.8
2. Sorokin I, Mamoulakis C, Miyazawa K, Rodgers A, Talati J, Lotan Y. Epidemiology of stone disease across the world. World J Urol. 2017;35(9):1301-1320. DOI: 10.1007/s00345-017-2008-6
3. Ferraro PM, Cunha TDS, Curhan GC. Sex Differences and the Risk of Kidney Stones. Semin Nephrol. 2022;42(2):230-235. DOI: 10.1016/j.semnephrol.2022.04.012
4. Edvardsson VO, Indridason OS, Haraldsson G, Kjartansson O, Palsson R. Temporal trends in the incidence of kidney stone disease. Kidney Int. 2013;83(1):146-152. Erratum in: Kidney Int. 2013;83(5):972. DOI: 10.1038/ki.2012.320
5. Institute for Health Metrics and Evaluation. GBD Results. Accessed on 9.05.2023 URL: https://www.healthdata.org/data-visualization/gbd-results
6. Gadzhiev N, Prosyannikov M, Malkhasyan V, Akopyan G, Somani B, Sivkov A, Apolikhin O, Kaprin A. Urolithiasis prevalence in the Russian Federation: analysis of trends over a 15-year period. World J Urol. 2021;39(10):3939-3944. DOI: 10.1007/s00345-021-03729-y
7. Chewcharat A, Curhan G. Trends in the prevalence of kidney stones in the United States from 2007 to 2016. Urolithiasis. 2021;49:27–39. DOI: 10.1007/s00240-020-01210-w
8. Moe OW. Kidney stones: pathophysiology and medical management. Lancet. 2006;367(9507):333-344. DOI: 10.1016/S0140-6736(06)68071-9
9. Alexander RT, Hemmelgarn BR, Wiebe N, Bello A, Morgan C, Samuel S, Klarenbach SW, Curhan GC, Tonelli M; Alberta Kidney Disease Network. Kidney stones and kidney function loss: a cohort study. BMJ. 2012;345:e5287. DOI: 10.1136/bmj.e5287
10. Shoag J, Halpern J, Goldfarb DS, Eisner BH. Risk of chronic and end stage kidney disease in patients with nephrolithiasis. J Urol. 2014;192(5):1440-1445. DOI: 10.1016/j.juro.2014.05.117
11. Green BW, Labagnara K, Feiertag N, Gupta K, Donnelly J, Watts KL, Crivelli JJ, Assimos DG, Small AC. Financial Toxicity of Nephrolithiasis: The First Assessment of the Economic Stresses of Kidney Stone Treatment. Urology. 2022;170:46-52. DOI: 10.1016/j.urology.2022.08.042
12. Litwin MS, Saigal CS, Yano EM, Avila C, Geschwind SA, Hanley JM, Joyce GF, Madison R, Pace J, Polich SM, Wang M; Urologic Diseases in America Project. Urologic diseases in America Project: analytical methods and principal findings. J Urol. 2005;173(3):933-937. DOI: 10.1097/01.ju.0000152365.43125.3b
13. Khan SR, Canales BK, Dominguez-Gutierrez PR. Randall’s plaque and calcium oxalate stone formation: role for immunity and inflammation. Nat Rev Nephrol. 2021;17(6):417-433. DOI: 10.1038/s41581-020-00392-1
14. Zou XC, Luo CW, Yuan RM, Jin MN, Zeng T, Chao HC. Develop a radiomics-based machine learning model to predict the stone-free rate post-percutaneous nephrolithotomy. Urolithiasis. 2024;52(1):64. DOI: 10.1007/s00240-024-01562-7
15. Sivalingam S, Streeper NM, Sehgal PD, Sninsky BC, Best SL, Nakada SY. Does Combination Therapy with Tamsulosin and Tolterodine Improve Ureteral Stent Discomfort Compared with Tamsulosin Alone? A Double-Blind, Randomized, Controlled Trial. J Urol. 2016;195(2):385-390. DOI: 10.1016/j.juro.2015.08.104
16. Yakoubi R, Lemdani M, Monga M, Villers A, Koenig P. Is there a role for α-blockers in ureteral stent related symptoms? A systematic review and meta-analysis. J Urol. 2011;186(3):928-934. DOI: 10.1016/j.juro.2011.04.061
17. Lucio J 2nd, Korkes F, Lopes-Neto AC, Silva EG, Mattos MH, Pompeo AC. Steinstrasse predictive factors and outcomes after extracorporeal shockwave lithotripsy. Int Braz J Urol. 2011;37(4):477-482. DOI: 10.1590/s1677-55382011000400006
18. Steinberg RL, Johnson BA, Sorokin I, Garbens A, Ganesan V, Crivelli J, Akhtar A, Antonelli J, Pearle M. PD34-02 natural history of residual fragments after aggressive ureteroscopy and fragment retrieval. Journal of Urology. 2020;203(Supplement 4):e711-e712. DOI: 10.1097/JU.0000000000000905.02
19. Fouke BW. An apatite for kidney stones. Nat. Geosci. 2022;15:692-693. DOI: 10.1038/s41561-022-01013-1
20. Sivaguru M, Lieske JC, Krambeck AE, Fouke BW. GeoBioMed sheds new light on human kidney stone crystallization and dissolution. Nat Rev Urol. 2020;17(1):1-2. DOI: 10.1038/s41585-019-0256-5
21. Haldar SK, Tišljar J. Chapter 2 – Basic Mineralogy. In: Haldar SK, Tišljar J, eds. Introduction to Mineralogy and Petrology. Oxford: Elsevier; 2020:39–79.
22. Broz M, Cook R, Whitney D. Microhardness, toughness, and modulus of Mohs scale minerals. American Mineralogist. 2006;91(1):135-142. DOI: 10.2138/am.2006.1844
23. Sivaguru M, Saw JJ, Williams JC Jr, Lieske JC, Krambeck AE, Romero MF, Chia N, Schwaderer AL, Alcalde RE, Bruce WJ, Wildman DE, Fried GA, Werth CJ, Reeder RJ, Yau PM, Sanford RA, Fouke BW. Geobiology reveals how human kidney stones dissolve in vivo. Sci Rep. 2018;8(1):13731. DOI: 10.1038/s41598-018-31890-9
24. Todorov LG, Sivaguru M, Krambeck AE, Lee MS, Lieske JC, Fouke BW. GeoBioMed perspectives on kidney stone recurrence from the reactive surface area of SWL-derived particles. Sci Rep. 2022;12(1):18371. DOI: 10.1038/s41598-022-23331-5
25. Manzoor MAP, Agrawal AK, Singh B, Mujeeburahiman M, Rekha PD. Morphological characteristics and microstructure of kidney stones using synchrotron radiation μCT reveal the mechanism of crystal growth and aggregation in mixed stones. PLoS One. 2019;14(3):e0214003. DOI: 10.1371/journal.pone.0214003
26. The European Association of Urology (EAU). Urolithiasis Guidelines. Accessed on 24.04.2024. URL: https://uroweb.org/guidelines/urolithiasis.
27. American Urological Association. Kidney Stones: Surgical Management Guideline. Accessed on 24.04.2024. URL: https://www.auanet.org/guidelines-and-quality/guidelines/kidney-stones-surgical-management-guideline
28. American Urological Association. Kidney Stones: Medical Mangement Guideline. Accessed on 24.04.2024. URL: https://www.auanet.org/guidelines-and-quality/guidelines/kidney-stones-medical-mangement-guideline
29. Geraghty RM, Davis NF, Tzelves L, Lombardo R, Yuan C, Thomas K, Petrik A, Neisius A, Türk C, Gambaro G, Skolarikos A, Somani BK. Best Practice in Interventional Management of Urolithiasis: An Update from the European Association of Urology Guidelines Panel for Urolithiasis 2022. Eur Urol Focus. 2023;9(1):199-208. DOI: 10.1016/j.euf.2022.06.014
30. Akram M, Jahrreiss V, Skolarikos A, Geraghty R, Tzelves L, Emilliani E, Davis NF, Somani BK. Urological Guidelines for Kidney Stones: Overview and Comprehensive Update. J Clin Med. 2024;13(4):1114. DOI: 10.3390/jcm13041114
31. Daudon M, Bader CA, Jungers P. Urinary calculi: review of classification methods and correlations with etiology. Scanning Microsc. 1993;7(3):1081-1104; discussion 1104-1106. PMID: 8146609
32. Daudon M, Dessombz A, Frochot V, Letavernier E, Haymann JP, Jungers P, Bazin D. Comprehensive morpho-constitutional analysis of urinary stones improves etiological diagnosis and therapeutic strategy of nephrolithiasis. Comptes Rendus Chim. 2016;19(11-12):1470-1491. DOI: 10.1016/j.crci.2016.05.008
33. Cloutier J, Villa L, Traxer O, Daudon M. Kidney stone analysis: “Give me your stone, I will tell you who you are!”. World J Urol. 2015;33(2):157-169. DOI: 10.1007/s00345-014-1444-9
34. Letavernier E, Bazin D, Daudon M. Description of Stone Morphology and Crystalluria Improve Diagnosis and Care of Kidney Stone Formers. Healthcare (Basel). 2022;11(1):2. DOI: 10.3390/healthcare11010002
35. Black KM, Law H, Aldoukhi A, Deng J, Ghani KR. Deep learning computer vision algorithm for detecting kidney stone composition. BJU Int. 2020;125(6):920-924. DOI: 10.1111/bju.15035
36. Tang K, Wang YD, Mostaghimi P, Knackstedt M, Hargrave C, Armstrong RT. Deep convolutional neural network for 3D mineral identification and liberation analysis. Minerals Engineering. 2022;183:107592. DOI: 10.1016/j.mineng.2022.107592
37. Wu B, Ji X, He M, Yang M, Zhang Z, Chen Y, Wang Y, Zheng X. Mineral Identification Based on Multi-Label Image Classification. Minerals. 2022;12(11):1338. DOI: 10.3390/min12111338
38. Long T, Zhou Z, Hancke G, Bai Y, Gao Q. A Review of Artificial Intelligence Technologies in Mineral Identification: Classification and Visualization. J Sens Actuator Netw. 2022;11(3):50. DOI: 10.3390/jsan11030050
39. Serrat J, Lumbreras F, Blanco F, Valiente M, López-Mesas M. myStone: A system for automatic kidney stone classification. Expert Syst Appl. 2017;89:41–51. DOI: 10.1016/j.eswa.2017.07.024
40. Stone L. Assessing kidney stone composition using deep learning. Nat Rev Urol. 2020;17:192-193. DOI: 10.1038/s41585-020-0301-4
41. Onal EG, Tekgul H. Assessing kidney stone composition using smartphone microscopy and deep neural networks. BJUI Compass. 2022;3(4):310-315. DOI: 10.1002/bco2.137
42. Fazil Marickar YM, Varma L, Koshy, P. Ultra structural study of laminated urinary stone. Urol Res. 2009;37:289-292. DOI: 10.1007/s00240-009-0210-8
43. Orhan K, ed. Micro-computed Tomography (micro-CT). In: Medicine and Engineering. Cham: Springer International Publishing, 2020. DOI: 10.1007/978-3-030-16641-0
44. Cnudde V, Boone MN. High-resolution X-ray computed tomography in geosciences: A review of the current technology and applications. Earth-Sci Rev. 2013;123:1-17. DOI: 10.1016/j.earscirev.2013.04.003
45. Williams JC Jr, Lingeman JE, Daudon M, Bazin D. Using micro computed tomographic imaging for analyzing kidney stones. C R Chim. 2021;24(Suppl 2):10.5802/crchim.89. DOI: 10.5802/crchim.89
46. Reedy CL. 3D Documentation and Analysis of Porosity in Deteriorated Historic Brick. Stud CONSERV. 2020;65:P258–P261. DOI: 10.1080/00393630.2020.1752426
47. Taud H, Martinez-Angeles R, Parrot JF, Hernandez-Escobedo L. Porosity estimation method by X-ray computed tomography. J Pet Sci Eng. 2005;47(3-4):209-217. DOI: 10.1016/j.petrol.2005.03.009
48. Saxena N, Hows A, Hofmann R, Alpak FO, Dietderich J, Appel M, Freeman J, Jong HD. Rock properties from micro-CT images: Digital rock transforms for resolution, pore volume, and field of view. AdV Water Resour. 2019;134:103419. DOI: 10.1016/j.advwatres.2019.103419
49. Gavin CT, Ali SN, Tailly T, Olvera-Posada D, Alenezi H, Power NE, Hou J, St. Amant AH, Luyt LG, Wood S, Wu C, Razvi H, Leong HS. Novel Methods of Determining Urinary Calculi Composition: Petrographic Thin Sectioning of Calculi and Nanoscale Flow Cytometry Urinalysis. Sci Rep. 2016;6:19328. DOI: 10.1038/srep19328
50. Liu H, Ren Y-L, Li X, Hu YX, Wu JP, Li B, Luo L, Tao Z, Liu X, Liang J, Zhang YY, An XY, Fang WK. Rock thin-section analysis and identification based on artificial intelligent technique. Pet Sci. 2022;19(4):1605–1621. DOI: 10.1016/j.petsci.2022.03.011
51. Canela VH, Bledsoe SB, Lingeman JE, Gerber G, Worcester EM, El-Achkar TM, Williams JC Jr. Demineralization and sectioning of human kidney stones: A molecular investigation revealing the spatial hetero-geneity of the stone matrix. Physiol Rep. 2021;9(1):e14658. DOI: 10.14814/phy2.14658
52. Racek M, Racek J, Hupáková I. Scanning electron microscopy in analysis of urinary stones. Scand J Clin Lab INVEST. 2019;79(3):208-217. DOI: 10.1080/00365513.2019.1578995
53. Henderickx MMEL, Stoots SJM, De Bruin DM, Wijkstra H, Freund JE, Wiseman OJ, Ploumidis A, Skolarikos A, Somani BK, Şener TE, Emiliani E, Dragos LB, Villa L, Talso M, Daudon M, Traxer O, Kronenberg P, Doizi S, Tailly T, Tefik T, Hendriks N, Beerlage HP, Baard J, Kamphuis GM. How Reliable Is Endoscopic Stone Recognition? A Comparison Between Visual Stone Identification and Formal Stone Analysis. J Endourol. 2022;36(10):1362-1370. DOI: 10.1089/end.2022.0217
54. Lopez F, Varelo A, Hinojosa O, Mendez M, Trinh DH, ElBeze Y, Hubert J, Estrade V, Gonzalez M, Ochoa G, Daul C. Assessing deep learning methods for the identification of kidney stones in endoscopic images. In: 43rd Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC), Mexico. 2021:2778-2781. DOI: 10.1109/EMBC46164.2021.9630211
55. Estrade V, Senneville BD de, Facq L, Daudon M. Endoscopic in-situ recognition of urinary stones during LASER-induced stone fragmentation: a modern, effective and essential approach in the diagnostic process in urolithiasis. Comptes Rendus Chim. 2022;25(1):407–416. DOI: 10.5802/crchim.162
56. De Coninck V, Skolarikos A, Juliebø-Jones P, Joris M, Traxer O, Keller EX. Advancements in stone classification: unveiling the beauty of urolithiasis. World J Urol. 2024;42(1):46. DOI: 10.1007/s00345-023-04746-9
57. Wang Y, Zhao Y, Therneau TM, Atkinson EJ, Tafti AP, Zhang N, Amin S, Limper AH, Khosla S, Liu H. Unsupervised machine learning for the discovery of latent disease clusters and patient subgroups using electronic health records. J Biomed Inform. 2020;102:103364. DOI: 10.1016/j.jbi.2019.103364
Review
For citations:
Popova E.O., Tkachev S.Y., Karpenko A.K., Lee Yu.A., Chislov P.A., Ali S.H., Dymov A.M., Vinarov A.Z., Akovantseva A.A., Ershov B.P., Golub D.A., Shchekleina M.D., Galechyan G.Y., Bogoedov D.A., Gafarova E.R., Musaelyan R.E., Timashev P.S. Multimodal analysis of renal stones to explore new biomarkers of urolithiasis. Urology Herald. 2024;12(4):121-134. (In Russ.) https://doi.org/10.21886/2308-6424-2024-12-4-121-134